Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 9, Pages 2967
Publisher
MDPI AG
Online
2020-09-15
DOI
10.3390/jcm9092967
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma
- (2020) Jon Røikjaer Henriksen et al. ACTA ONCOLOGICA
- Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer
- (2020) Feiyue Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities
- (2020) Joana R. Lérias et al. Frontiers in Microbiology
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- The adverse events associated with combination immunotherapy in cancers: Challenges and chances
- (2020) Minglei Zhuo et al. Asia-Pacific Journal of Clinical Oncology
- Cancer-associated mucins: role in immune modulation and metastasis
- (2019) Rakesh Bhatia et al. CANCER AND METASTASIS REVIEWS
- Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
- (2019) Locke D. Uppendahl et al. GYNECOLOGIC ONCOLOGY
- Immunotherapy in ovarian cancer: fake news or the real deal?
- (2019) Christian Marth et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
- (2019) Sabine Heublein et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
- (2019) Fernando Souza-Fonseca-Guimaraes et al. TRENDS IN IMMUNOLOGY
- Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
- (2019) Kaipeng Xie et al. Journal of Ovarian Research
- T Cell-Redirecting Strategies to ‘STAb’ Tumors: Beyond CARs and Bispecific Antibodies
- (2019) Belén Blanco et al. TRENDS IN IMMUNOLOGY
- The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
- (2019) Stacy A. Malaker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
- (2019) Qinglei Gao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
- (2019) Rüdiger Klapdor et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer
- (2019) Marco Greppi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic activation of POTE genes in ovarian cancer
- (2019) Ashok Sharma et al. Epigenetics
- Nanobody: outstanding features for diagnostic and therapeutic applications
- (2019) J.-Pablo Salvador et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Epithelial ovarian cancer: Evolution of management in the era of precision medicine
- (2019) Stephanie Lheureux et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication
- (2019) Rosalba De Nola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
- (2019) Quentin Haas et al. Cancer Immunology Research
- Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
- (2019) Stefan Mereiter et al. CANCER CELL
- Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy for Treatment of Malignant Pleural Mesothelioma
- (2019) Raffit Hassan et al. CLINICAL CANCER RESEARCH
- Ovarian Cancer Immunotherapy: Turning up the Heat
- (2019) Eleonora Ghisoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
- (2019) Krishnansu S. Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- Programmable bacteria induce durable tumor regression and systemic antitumor immunity
- (2019) Sreyan Chowdhury et al. NATURE MEDICINE
- Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities
- (2019) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- B Cells as an Immune-Regulatory Signature in Ovarian Cancer
- (2019) Gupta et al. Cancers
- The emerging role of epigenetic therapeutics in immuno-oncology
- (2019) Michael J. Topper et al. Nature Reviews Clinical Oncology
- Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
- (2019) Lízbeth Ayala-Domínguez et al. Frontiers in Oncology
- Blockade of the CD47-SIRPα axis: a promising approach for cancer immunotherapy
- (2019) Robert Uger et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
- (2019) Vinicia A. Polito et al. Frontiers in Immunology
- Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors
- (2019) Sooyeon Oh et al. Cancers
- Biomarkers that may predict response to immunotherapy in ovarian malignancies
- (2019) Curtis D. Chin et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer
- (2019) Liina Salminen et al. GYNECOLOGIC ONCOLOGY
- Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
- (2019) Jenna H. Newman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Contribution of Angiogenesis to Inflammation and Cancer
- (2019) Dolores Aguilar-Cazares et al. Frontiers in Oncology
- Enzyme decorated drug carriers: Targeted swords to cleave and overcome the mucus barrier
- (2018) Claudia Menzel et al. ADVANCED DRUG DELIVERY REVIEWS
- Cell Biology of T Cell Receptor Expression and Regulation
- (2018) Andrés Alcover et al. Annual Review of Immunology
- Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and Microbes
- (2018) Megan B. Barnet et al. BIOESSAYS
- Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior
- (2018) Ilaria Giusti et al. CANCER BIOLOGY & THERAPY
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- IDO1 in cancer: a Gemini of immune checkpoints
- (2018) Lijie Zhai et al. Cellular & Molecular Immunology
- Consensus on Molecular Subtypes of High-grade Serous Ovarian Carcinoma
- (2018) Gregory M Chen et al. CLINICAL CANCER RESEARCH
- CD103+Tumor-Resident CD8+T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
- (2018) Jarem Edwards et al. CLINICAL CANCER RESEARCH
- Using the glycan toolbox for pathogenic interventions and glycan immunotherapy
- (2018) RJ Eveline Li et al. CURRENT OPINION IN BIOTECHNOLOGY
- Cancer: the dark side of wound healing
- (2018) Gopinath M. Sundaram et al. FEBS Journal
- Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies
- (2018) Paul Mayor et al. GYNECOLOGIC ONCOLOGY
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
- (2018) David Porter et al. Journal of Hematology & Oncology
- Gamma-delta (γδ) T cells: friend or foe in cancer development?
- (2018) Yijing Zhao et al. Journal of Translational Medicine
- The promise and challenges of immune agonist antibody development in cancer
- (2018) Patrick A. Mayes et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
- (2018) Paula Salmikangas et al. PHARMACEUTICAL RESEARCH
- Precision medicine using microbiota
- (2018) Christian Jobin SCIENCE
- CAR-T cells: the long and winding road to solid tumors
- (2018) Maria Michela D’Aloia et al. Cell Death & Disease
- Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers
- (2018) Daisuke Fukagawa et al. Oncotarget
- Current status and future directions of cancer immunotherapy
- (2018) Hongming Zhang et al. Journal of Cancer
- CD8 + T cells and NK cells: parallel and complementary soldiers of immunotherapy
- (2018) Jillian Rosenberg et al. Current Opinion in Chemical Engineering
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors
- (2018) Maxim Kebenko et al. OncoImmunology
- Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition
- (2018) Zoë Blake et al. Journal for ImmunoTherapy of Cancer
- Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
- (2018) Emily Rodrigues et al. Cancers
- With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment
- (2018) Elizabeth Harper et al. Cancers
- Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer
- (2018) Mauricio P. Pinto et al. GYNECOLOGIC ONCOLOGY
- Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
- (2018) Michal A. Stanczak et al. JOURNAL OF CLINICAL INVESTIGATION
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- Epigenetic control of innate and adaptive immune memory
- (2018) Colleen M. Lau et al. NATURE IMMUNOLOGY
- Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
- (2018) Olga Gordeeva SEMINARS IN CANCER BIOLOGY
- Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
- (2018) Alia Ghoneum et al. Cancer Medicine
- Description of CD8+ Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer
- (2018) Martha R. Vieyra-Lobato et al. Journal of Immunology Research
- Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy
- (2018) Nina Dumauthioz et al. Frontiers in Immunology
- Resident memory T cells, critical components in tumor immunology
- (2018) Fathia Mami-Chouaib et al. Journal for ImmunoTherapy of Cancer
- Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
- (2018) Curtis McCloskey et al. Cancers
- The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
- (2018) Galaxia Rodriguez et al. Cancers
- The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer
- (2018) Sudha Savant et al. Cancers
- Targeting the Microenvironment in High Grade Serous Ovarian Cancer
- (2018) Nkechiyere Nwani et al. Cancers
- Detection of N-glycolylneuraminic acid biomarkers in sera from patients with ovarian cancer using an engineered N-glycolylneuraminic acid-specific lectin SubB2M
- (2018) L.K. Shewell et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The 2018 Nobel Prize in medicine goes to cancer immunotherapy
- (2018) Zong Sheng Guo BMC CANCER
- The clinical role of the TME in solid cancer
- (2018) Nicolas A. Giraldo et al. BRITISH JOURNAL OF CANCER
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- First CAR to Pass the Road Test: Tisagenlecleucel's Drive to FDA Approval
- (2018) Mark B. Geyer CLINICAL CANCER RESEARCH
- Biological Consequences of Major Histocompatibility Class-II Expression by Tumor Cells in Cancer
- (2018) Margaret L Axelrod et al. CLINICAL CANCER RESEARCH
- Review of Immune Therapies Targeting Ovarian Cancer
- (2018) Cong Fan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- The fallopian tube, “precursor escape” and narrowing the knowledge gap to the origins of high-grade serous carcinoma
- (2018) Thing Rinda Soong et al. GYNECOLOGIC ONCOLOGY
- Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
- (2018) Julia L. Boland et al. GYNECOLOGIC ONCOLOGY
- Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer
- (2018) Debra L. Richardson et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Overview of CD24 as a new molecular marker in ovarian cancer
- (2018) Vahideh Tarhriz et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Universal CARs, universal T cells, and universal CAR T cells
- (2018) Juanjuan Zhao et al. Journal of Hematology & Oncology
- Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models
- (2018) Alfredo Perales-Puchalt et al. MOLECULAR THERAPY
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- What, Why, Where, and When: Bringing Timing to Immuno-Oncology
- (2018) Adrienne M. Rothschilds et al. TRENDS IN IMMUNOLOGY
- Adoptive cellular therapies: the current landscape
- (2018) Maartje W. Rohaan et al. VIRCHOWS ARCHIV
- CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
- (2018) Stephanie Vairy et al. Drug Design Development and Therapy
- Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells
- (2018) John P. Murad et al. Frontiers in Immunology
- Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells
- (2018) Camille Khairallah et al. Frontiers in Immunology
- Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
- (2018) Maria Georganaki et al. Frontiers in Immunology
- Antibody–drug conjugates for ovarian cancer
- (2018) Daphne Stewart et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- B cell and B cell-related pathways for novel cancer treatments
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
- (2017) Ricardo Coelho et al. Expert Review of Anticancer Therapy
- Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer
- (2017) Olivia Joan Adams et al. GLYCOBIOLOGY
- T-cell target antigens across major gynecologic cancers
- (2017) Alba Rodriguez-Garcia et al. GYNECOLOGIC ONCOLOGY
- Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
- (2017) Abhishek D. Garg et al. IMMUNOLOGICAL REVIEWS
- Viewing Siglecs through the lens of tumor immunology
- (2017) Isabella Fraschilla et al. IMMUNOLOGICAL REVIEWS
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment
- (2017) Qiaohong Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- N -Glycosylation affects the stability and barrier function of the MUC16 mucin
- (2017) Takazumi Taniguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human regulatory B cells in health and disease: therapeutic potential
- (2017) Claudia Mauri et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation
- (2017) Jin Dai et al. Journal of Hematology & Oncology
- The mechanisms tumor cells utilize to evade the host's immune system
- (2017) Nyanbol Kuol et al. MATURITAS
- Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
- (2017) Zongyuan Yang et al. Molecular Cancer
- The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer
- (2017) Elisa Zanini et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The immunopeptidomic landscape of ovarian carcinomas
- (2017) Heiko Schuster et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
- (2017) Sanja Stevanović et al. SCIENCE
- Gut microbes shape response to cancer immunotherapy
- (2017) Jocelyn Kaiser SCIENCE
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- NK cell-based immunotherapy for cancer
- (2017) Fang Fang et al. SEMINARS IN IMMUNOLOGY
- Immunotoxin: A new tool for cancer therapy
- (2017) Hossein Allahyari et al. TUMOR BIOLOGY
- Reconstructing the immune system with lentiviral vectors
- (2017) Henning Olbrich et al. VIRUS GENES
- Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer
- (2017) Filippo Veglia et al. Nature Communications
- Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement
- (2017) James Bradford Kline et al. Oncotarget
- The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer
- (2017) Jun Li et al. Oncotarget
- CAR-T cell therapy in ovarian cancer: from the bench to the bedside
- (2017) Xinxin Zhu et al. Oncotarget
- New strategies for cancer immunotherapy: targeting regulatory T cells
- (2017) Francesca Finotello et al. Genome Medicine
- The basics of CAR T design and challenges in immunotherapy of solid tumors — Ovarian cancer as a model
- (2017) Xuequn Xu et al. Human Vaccines & Immunotherapeutics
- Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
- (2017) Jiangtao Ren et al. Protein & Cell
- Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma
- (2017) Kun Jiang et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- VSV based virotherapy in ovarian cancer: the past, the present and …future?
- (2017) Beata Urszula Orzechowska et al. Journal of Cancer
- New Chimeric Antigen Receptor Design for Solid Tumors
- (2017) Yuedi Wang et al. Frontiers in Immunology
- FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
- (2017) Sara Caratelli et al. Frontiers in Immunology
- Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
- (2017) Peter Bannas et al. Frontiers in Immunology
- Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation
- (2017) Maulik Vyas et al. OncoImmunology
- Trial Watch: Adoptively transferred cells for anticancer immunotherapy
- (2017) Carole Fournier et al. OncoImmunology
- Trial watch: DNA-based vaccines for oncological indications
- (2017) Stefano Pierini et al. OncoImmunology
- Trial watch: Immune checkpoint blockers for cancer therapy
- (2017) Claire Vanpouille-Box et al. OncoImmunology
- Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression
- (2017) Brooke E. Howitt et al. OncoImmunology
- Global Manufacturing of CAR T Cell Therapy
- (2017) Bruce L. Levine et al. Molecular Therapy-Methods & Clinical Development
- Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
- (2017) et al. JAMA Oncology
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- Epigenetics and Trained Immunity
- (2017) Charlotte D.C.C. van der Heijden et al. ANTIOXIDANTS & REDOX SIGNALING
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
- (2016) J. M. Pitt et al. ANNALS OF ONCOLOGY
- Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target
- (2016) Alfredo Perales-Puchalt et al. CLINICAL CANCER RESEARCH
- PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
- (2016) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
- (2016) Nicole E. Scharping et al. IMMUNITY
- Specific immunotherapy in ovarian cancer: a systematic review
- (2016) Soroush Alipour et al. Immunotherapy
- Immune checkpoint inhibition in ovarian cancer
- (2016) Junzo Hamanishi et al. INTERNATIONAL IMMUNOLOGY
- Dendritic cell–derived exosomes for cancer therapy
- (2016) Jonathan M. Pitt et al. JOURNAL OF CLINICAL INVESTIGATION
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
- (2016) Raffit Hassan et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic targets and new directions for antibodies developed for ovarian cancer
- (2016) Heather J. Bax et al. mAbs
- “No patient left behind”: an alternative to “the War on Cancer” metaphor
- (2016) Bryan T. Oronsky et al. MEDICAL ONCOLOGY
- The human fetoembryonic defense system hypothesis: Twenty years on
- (2016) Poh-Choo Pang et al. MOLECULAR ASPECTS OF MEDICINE
- Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
- (2016) Mark J Osborn et al. MOLECULAR THERAPY
- Precision glycocalyx editing as a strategy for cancer immunotherapy
- (2016) Han Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic cells as gatekeepers of tolerance
- (2016) Ari Waisman et al. Seminars in Immunopathology
- Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis
- (2016) Jiuyang Liu et al. TUMOR BIOLOGY
- Measles to the Rescue: A Review of Oncolytic Measles Virus
- (2016) Sarah Aref et al. Viruses-Basel
- Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases
- (2016) Justyna Mikuła-Pietrasik et al. Cell Death & Disease
- Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancer
- (2016) Chao Zhang et al. Oncotarget
- Hallmarks of glycosylation in cancer
- (2016) Jennifer Munkley et al. Oncotarget
- The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
- (2016) Kankana Bardhan et al. Frontiers in Immunology
- Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
- (2016) Ming Cheng et al. OncoImmunology
- Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen
- (2016) C. Fu et al. HLA
- Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
- (2016) Ping-Chih Ho et al. Journal for ImmunoTherapy of Cancer
- Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
- (2016) Vita Golubovskaya et al. Cancers
- IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
- (2015) K Abiko et al. BRITISH JOURNAL OF CANCER
- HER2 expression status in diverse cancers: review of results from 37,992 patients
- (2015) Min Yan et al. CANCER AND METASTASIS REVIEWS
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies
- (2015) Laurent Poirot et al. CANCER RESEARCH
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment
- (2015) Shuping Zhang et al. Cellular & Molecular Immunology
- Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo
- (2015) Justyna Mikuła-Pietrasik et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
- (2015) M. P. Mak et al. CLINICAL CANCER RESEARCH
- Immunotherapy for Ovarian Cancer
- (2015) Justin M. Drerup et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Genetically modified T cells in cancer therapy: opportunities and challenges
- (2015) M. Sharpe et al. Disease Models & Mechanisms
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- DNA methylation changes in epithelial ovarian cancer histotypes
- (2015) Madalene A. Earp et al. GENOMICS
- Eradicating ovarian cancer stem cells by targeting the tumor-associated carbohydrate antigen sialyl Tn
- (2015) K. Starbuck et al. GYNECOLOGIC ONCOLOGY
- In Vitro Antiproliferative Activity of Fresh Pineapple Juices on Ovarian and Colon Cancer Cell Lines
- (2015) Madihah Binti Abdul Gani et al. International Journal of Peptide Research and Therapeutics
- CAR therapy: the CD19 paradigm
- (2015) Michel Sadelain JOURNAL OF CLINICAL INVESTIGATION
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity
- (2015) Ming-Ru Wu et al. JOURNAL OF IMMUNOLOGY
- A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
- (2015) Mythili Koneru et al. Journal of Translational Medicine
- Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
- (2015) Connie P.M. Duong et al. MOLECULAR IMMUNOLOGY
- In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
- (2015) Linda Hammerich et al. Molecular Oncology
- Cancer immunotherapy: Strategies for personalization and combinatorial approaches
- (2015) Vishwanath Sathyanarayanan et al. Molecular Oncology
- Nanobody-based cancer therapy of solid tumors
- (2015) Marta Kijanka et al. Nanomedicine
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
- (2015) Ende Zhao et al. NATURE IMMUNOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Releasing the Brakes on Cancer Immunotherapy
- (2015) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients
- (2015) Xin Wei et al. TUMOR BIOLOGY
- Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
- (2015) Masami Suzuki et al. Journal of Toxicologic Pathology
- Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
- (2015) Miles A. Miller et al. Nature Communications
- Adaptive Immune Resistance: How Cancer Protects from Immune Attack
- (2015) A. Ribas Cancer Discovery
- Bromelain: A natural proteolytic for intra-abdominal adhesion prevention
- (2015) Ahmet Sahbaz et al. International Journal of Surgery
- Epigenetic synergy between decitabine and platinum derivatives
- (2015) Taichun Qin et al. Clinical Epigenetics
- Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer
- (2015) K. Urbanska et al. Cancer Immunology Research
- T Lymphocyte–Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific Immunity
- (2015) Christopher V. Carman et al. Frontiers in Immunology
- Are BiTEs the “missing link” in cancer therapy?
- (2015) Carter M Suryadevara et al. OncoImmunology
- Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy
- (2015) H. Michael Shepard Frontiers in Oncology
- Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus
- (2015) Indira Guleria et al. Biomedical Journal
- Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
- (2015) Franco Dosio et al. Recent Patents on Anti-Cancer Drug Discovery
- Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix
- (2014) Alessandro Parodi et al. ACS Nano
- Nanoparticle-Based Immunotherapy for Cancer
- (2014) Kun Shao et al. ACS Nano
- Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches
- (2014) Hyun-Jin Choi et al. CANCER AND METASTASIS REVIEWS
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer
- (2014) E. Galanis et al. CANCER RESEARCH
- Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer
- (2014) Assaf Marcus et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- MUC16: molecular analysis and its functional implications in benign and malignant conditions
- (2014) Dhanya Haridas et al. FASEB JOURNAL
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Bispecific T-cell engagers for cancer immunotherapy
- (2014) Amelia M Huehls et al. IMMUNOLOGY AND CELL BIOLOGY
- Evolutionary mechanism unifies the hallmarks of cancer
- (2014) Steven D. Horne et al. INTERNATIONAL JOURNAL OF CANCER
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours
- (2014) Sara Ricardo et al. Molecular Oncology
- Cancer's Off Switch
- (2014) Jedd D. Wolchok SCIENTIFIC AMERICAN
- Tertiary lymphoid structures in cancer and beyond
- (2014) Marie-Caroline Dieu-Nosjean et al. TRENDS IN IMMUNOLOGY
- T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
- (2014) I. Melero et al. Cancer Discovery
- Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
- (2014) Franca Maria Tuccillo et al. Biomed Research International
- The Immunological Synapse
- (2014) M. L. Dustin Cancer Immunology Research
- Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer
- (2014) Cynthia M. Fehres et al. Frontiers in Immunology
- Clinical Applications of Gamma Delta T Cells with Multivalent Immunity
- (2014) Drew C. Deniger et al. Frontiers in Immunology
- Location, location, location
- (2014) John R Webb et al. OncoImmunology
- Antibody-based immunotherapy for ovarian cancer: where are we at?
- (2013) B. W. C. Tse et al. ANNALS OF ONCOLOGY
- CTLA-4 and autoimmunity: New insights into the dual regulator of tolerance
- (2013) Jorge Romo-Tena et al. AUTOIMMUNITY REVIEWS
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- Modulation of Tumor Immunity by Soluble and Membrane-Bound Molecules at the Immunological Synapse
- (2013) Pablo A. González et al. Clinical & Developmental Immunology
- Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer
- (2013) J. R. Webb et al. CLINICAL CANCER RESEARCH
- Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer
- (2013) Pierre-Emmanuel Colombo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
- (2013) Joel Crespo et al. CURRENT OPINION IN IMMUNOLOGY
- Assessment of Sialic Acid Diversity in Cancer- and Non-Cancer Related CA125 Antigen Using Sialic Acid-Binding Ig-Like Lectins (Siglecs)
- (2013) N. Mitic et al. DISEASE MARKERS
- Engineering T cells for cancer: our synthetic future
- (2013) Robert H. Vonderheide et al. IMMUNOLOGICAL REVIEWS
- Design and development of therapies using chimeric antigen receptor-expressing T cells
- (2013) Gianpietro Dotti et al. IMMUNOLOGICAL REVIEWS
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- A formulation forin situlysis of mucin secreted in pseudomyxoma peritonei
- (2013) Krishna Pillai et al. INTERNATIONAL JOURNAL OF CANCER
- Exploring the Glycosylation of Serum CA125
- (2013) Radka Saldova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
- (2013) Michael S. Anglesio et al. PLoS One
- Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells
- (2013) E. Wakamatsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Targeting Tregs in Malignant Brain Cancer: Overcoming IDO
- (2013) Derek A. Wainwright et al. Frontiers in Immunology
- Epigenetic regulation of NK cell differentiation and effector functions
- (2013) Frank Cichocki et al. Frontiers in Immunology
- TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
- (2013) Andre Kunert et al. Frontiers in Immunology
- Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
- (2012) J. B. Mitchem et al. CANCER RESEARCH
- Role of Farletuzumab in Epithelial Ovarian Carcinoma
- (2012) Danijela Jelovac et al. CURRENT PHARMACEUTICAL DESIGN
- Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
- (2012) Russell Vang et al. HISTOPATHOLOGY
- Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis
- (2012) Yuan Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Novel Monoclonal Antibodies for Cancer Treatment: The Trifunctional Antibody Catumaxomab (Removab®)
- (2012) Diane Seimetz Journal of Cancer
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trained Immunity: A Memory for Innate Host Defense
- (2011) Mihai G. Netea et al. Cell Host & Microbe
- Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer
- (2011) Rachel N Grisham et al. Immunotherapy
- Evolution of platinum resistance in high-grade serous ovarian cancer
- (2011) Susanna L Cooke et al. LANCET ONCOLOGY
- HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
- (2011) M. Gooden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
- (2010) Christopher G. Przybycin et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Regulatory T Cell as a Target for Cancer Therapy
- (2010) Lucas Cunha Dias de Rezende et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cancer models, genomic instability and somatic cellular Darwinian evolution
- (2010) Mark P Little Biology Direct
- Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75
- (2010) M C Ryan et al. BRITISH JOURNAL OF CANCER
- Macrophage Expression of Hypoxia-Inducible Factor-1 Suppresses T-Cell Function and Promotes Tumor Progression
- (2010) A. L. Doedens et al. CANCER RESEARCH
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients
- (2010) Roger W. McGilvray et al. INTERNATIONAL JOURNAL OF CANCER
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
- (2010) Jennifer AA Gubbels et al. Molecular Cancer
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- Adaptive Therapy
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Costimulatory and coinhibitory receptors in anti-tumor immunity
- (2009) Gregory Driessens et al. IMMUNOLOGICAL REVIEWS
- Autophagy and Its Role in MHC-Mediated Antigen Presentation
- (2009) V. L. Crotzer et al. JOURNAL OF IMMUNOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Critical molecular abnormalities in high-grade serous carcinoma of the ovary
- (2008) Martin Köbel et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
- (2008) Brian T. Fife et al. IMMUNOLOGICAL REVIEWS
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started